KeyBank National Association
UTHR icon

KeyBank National Association’s United Therapeutics UTHR Stock Holding History

KeyBank National Association’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,066
Closed -$382K – 1294
2014
Q1 		$382K Buy
4,066
+200
+5% +$20.5K ﹤0.01% 1000
2013
Q4 		$437K Sell
3,866
-5
-0.1% -$451 ﹤0.01% 952
2013
Q3 		$305K Buy
3,871
+130
+3% +$9.5K ﹤0.01% 1046
2013
Q2 		$246K Buy
+3,741
New +$241K ﹤0.01% 1181

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

KeyBank National Association's UTHR Position: Q2 2014 in Review

KeyBank National Association sold out of United Therapeutics (UTHR) in Q2 2014, closing a stake of 4,066 shares — an estimated $382K sold.

KeyBank National Association first reported a position in UTHR in Q2 2013 and held it in 4 quarters. The position peaked at $437K in Q4 2013. 303 funds tracked by Wall St. Rank hold UTHR as of Q2 2014.

  • KeyBank National Association reported no remaining United Therapeutics position as of Q2 2014 after selling out during the quarter.
  • KeyBank National Association sold 4,066 United Therapeutics shares in Q2 2014, an estimated $382K.
  • KeyBank National Association first reported a position in United Therapeutics in Q2 2013 and held it in 4 quarters.
  • KeyBank National Association's United Therapeutics position peaked at $437K in Q4 2013.
  • 303 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2014.

Based on KeyBank National Association's 13F filing for Q2 2014, filed 13 Aug 2014.